Genetic variation that determines TAPBP expression levels associates with the course of malaria in an HLA allotype-dependent manner.

Walker-Sperling, Victoria, Jean C Digitale, Mathias Viard, Maureen P Martin, Arman Bashirova, Yuko Yuki, Veron Ramsuran, et al. 2022. “Genetic Variation That Determines TAPBP Expression Levels Associates With the Course of Malaria in an HLA Allotype-Dependent Manner.”. Proceedings of the National Academy of Sciences of the United States of America 119 (29): e2205498119.

Abstract

HLA class I (HLA-I) allotypes vary widely in their dependence on tapasin (TAPBP), an integral component of the peptide-loading complex, to present peptides on the cell surface. We identified two single-nucleotide polymorphisms that regulate TAPBP messenger RNA (mRNA) expression in Africans, rs111686073 (G/C) and rs59097151 (A/G), located in an AP-2α transcription factor binding site and a microRNA (miR)-4486 binding site, respectively. rs111686073G and rs59097151A induced significantly higher TAPBP mRNA expression relative to the alternative alleles due to higher affinity for AP-2α and abrogation of miR-4486 binding, respectively. These variants associated with lower Plasmodium falciparum parasite prevalence and lower incidence of clinical malaria specifically among individuals carrying tapasin-dependent HLA-I allotypes, presumably by augmenting peptide loading, whereas tapasin-independent allotypes associated with relative protection, regardless of imputed TAPBP mRNA expression levels. Thus, an attenuated course of malaria may occur through enhanced breadth and/or magnitude of antigen presentation, an important consideration when evaluating vaccine efficacy.

Last updated on 03/27/2023
PubMed